Published in Acta Neurol Scand on January 01, 2005
The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry (2007) 1.06
Scales in Parkinson's disease. J Neurol (2006) 1.02
Treatment of idiopathic Parkinson's disease with traditional chinese herbal medicine: a randomized placebo-controlled pilot clinical study. Evid Based Complement Alternat Med (2011) 0.95
Review: management of Parkinson's disease. Neuropsychiatr Dis Treat (2013) 0.93
Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord (2012) 0.92
The wearing-off phenomenon and the use of questionnaires to facilitate its recognition in Parkinson's disease. J Neural Transm (Vienna) (2010) 0.90
Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo). Neuropsychiatr Dis Treat (2010) 0.79
Willingness to pay for a new drug delivery in Parkinson patients. J Multidiscip Healthc (2014) 0.79
Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson's disease experiencing mild wearing-off: a randomised, double-blind trial. J Neural Transm (Vienna) (2013) 0.79
Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options. P T (2015) 0.75
LSVT-BIG Improves UPDRS III Scores at 4 Weeks in Parkinson's Disease Patients with Wearing Off: A Prospective, Open-Label Study. Parkinsons Dis (2017) 0.75
Self-reported health in people with Parkinson's disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry (2006) 0.75
Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med (1991) 4.09
Selective attention enhances the auditory 40-Hz transient response in humans. Nature (1993) 2.68
Attentive novelty detection in humans is governed by pre-attentive sensory memory. Nature (1994) 2.02
Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke (1988) 1.74
Temporal window of integration revealed by MMN to sound omission. Neuroreport (1997) 1.41
Epilepsy and pregnancy: lamotrigine as main drug used. Acta Neurol Scand (2004) 1.36
A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest (1993) 1.32
Seasonal patterns in the physiology of the European brown bear (Ursus arctos arctos) in Finland. Comp Biochem Physiol A Physiol (1994) 1.26
Delirium among elderly persons admitted to a psychiatric hospital: clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand (1989) 1.25
Event-related brain potential of human newborns to pitch change of an acoustic stimulus. Electroencephalogr Clin Neurophysiol (1990) 1.22
Responses of the primary auditory cortex to pitch changes in a sequence of tone pips: neuromagnetic recordings in man. Neurosci Lett (1984) 1.16
Human somatosensory evoked potentials to mechanical pulses and vibration: contributions of SI and SII somatosensory cortices to P50 and P100 components. Electroencephalogr Clin Neurophysiol (1990) 1.14
Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke (1988) 1.10
Mismatch negativity indicates vowel discrimination in newborns. Hear Res (1995) 1.10
Separate representation of stimulus frequency, intensity, and duration in auditory sensory memory: an event-related potential and dipole-model analysis. J Cogn Neurosci (1995) 1.09
Frequency and location specificity of the human vertex N1 wave. Electroencephalogr Clin Neurophysiol (1988) 1.08
Do event-related potentials reveal the mechanism of the auditory sensory memory in the human brain? Neurosci Lett (1989) 1.08
Right hemisphere dominance of different mismatch negativities. Electroencephalogr Clin Neurophysiol (1991) 1.08
Somatosensory evoked cerebral magnetic fields from SI and SII in man. Electroencephalogr Clin Neurophysiol (1984) 1.04
Cerebral neuromagnetic responses evoked by short auditory stimuli. Electroencephalogr Clin Neurophysiol (1985) 1.03
Auditory and somatosensory event-related brain potentials in early blind humans. Exp Brain Res (1995) 1.02
Mismatch negativity to auditory stimulus change recorded directly from the human temporal cortex. Psychophysiology (1995) 1.00
The effect of small variation of the frequent auditory stimulus on the event-related brain potential to the infrequent stimulus. Psychophysiology (1990) 0.98
Rate effect and mismatch responses in the somatosensory system: ERP-recordings in humans. Biol Psychol (1997) 0.97
Mismatch negativity to change in spatial location of an auditory stimulus. Electroencephalogr Clin Neurophysiol (1989) 0.96
The tolerability and efficacy of entacapone over 3 years in patients with Parkinson's disease. Eur J Neurol (2003) 0.95
The ontogenetically earliest discriminative response of the human brain. Psychophysiology (1996) 0.94
Do event-related potentials to infrequent decrements in duration of auditory stimuli demonstrate a memory trace in man? Neurosci Lett (1989) 0.94
Selective tuning of the left and right auditory cortices during spatially directed attention. Brain Res Cogn Brain Res (1999) 0.93
Does selegiline modify the progression of early Parkinson's disease? Results from a five-year study. The Norwegian-Danish Study Group. Eur J Neurol (1999) 0.92
Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. Acta Neurol Scand (1996) 0.92
Event-related potentials to repetition and change of auditory stimuli. Electroencephalogr Clin Neurophysiol (1992) 0.89
Histamine neurons in human hypothalamus: anatomy in normal and Alzheimer diseased brains. Neuroscience (1991) 0.89
Aging effects on auditory processing: an event-related potential study. Exp Aging Res (1996) 0.89
Interstimulus interval and the selective-attention effect on auditory ERPs: "N1 enhancement" versus processing negativity. Psychophysiology (1993) 0.89
Neuromagnetic responses from the second somatosensory cortex in man. Acta Neurol Scand (1983) 0.89
Brain mechanism of selective listening reflected by event-related potentials. Electroencephalogr Clin Neurophysiol (1987) 0.88
The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group. Mov Disord (1997) 0.88
Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa. Acta Neurol Scand (1985) 0.88
Auditory sensory memory impairment in Alzheimer's disease: an event-related potential study. Neuroreport (1994) 0.87
Event-related potentials to pitch change in an auditory stimulus sequence during sleep. Electroencephalogr Clin Neurophysiol Suppl (1987) 0.86
Automatic auditory discrimination is impaired in Parkinson's disease. Electroencephalogr Clin Neurophysiol (1995) 0.85
Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand (1993) 0.85
Neuromagnetic localization of cortical activity evoked by painful dental stimulation in man. Neurosci Lett (1983) 0.85
Stimulus selection during auditory spatial attention as expressed by event-related potentials. Biol Psychol (1987) 0.85
The mismatch negativity to intensity changes in an auditory stimulus sequence. Electroencephalogr Clin Neurophysiol Suppl (1987) 0.84
Event-related potentials reveal a memory trace for temporal features. Neuroreport (1993) 0.83
Lack of adverse interactions between concomitantly administered selegiline and citalopram. Clin Neuropharmacol (1997) 0.83
Maturation of mismatch negativity in infants. Int J Psychophysiol (1998) 0.83
A four-channel SQUID magnetometer for brain research. Electroencephalogr Clin Neurophysiol (1984) 0.83
Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's disease. Neurosci Lett (1991) 0.82
Event-related brain potentials reflect traces of echoic memory in humans. Percept Psychophys (1993) 0.82
Is the somatosensory N250 related to deviance discrimination or conscious target detection? Electroencephalogr Clin Neurophysiol (1996) 0.82
Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions (1991) 0.80
Mismatch negativity (MMN) for sequences of auditory and visual stimuli: evidence for a mechanism specific to the auditory modality. Electroencephalogr Clin Neurophysiol (1991) 0.80
Separability of different negative components of the event-related potential associated with auditory stimulus processing. Psychophysiology (1986) 0.79
Reoperation for recurrent bronchogenic carcinoma. Scand J Thorac Cardiovasc Surg (1984) 0.79
Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease. Neurosci Lett (1998) 0.79
Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation. Neurology (2002) 0.78
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy. Ann Oncol (1992) 0.78
Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites. Acta Neurol Scand (1992) 0.78
The activation of unmyelinated or myelinated afferent fibers by brief infrared laser pulses varies with skin type. Brain Res (1984) 0.78
Slowing of the dominant occipital rhythm in electroencephalogram is associated with low concentration of noradrenaline in the thalamus in patients with Alzheimer's disease. Neurosci Lett (1992) 0.78
Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease. Eur J Clin Pharmacol (2000) 0.78
Pharmacokinetics of oral entacapone after frequent multiple dosing and effects on levodopa disposition. Eur J Clin Pharmacol (1999) 0.77
Selegiline treatment facilitates recovery after stroke. Neurorehabil Neural Repair (2001) 0.77
Event-related brain potentials reflecting processing of relevant and irrelevant stimuli during selective listening. Psychophysiology (1989) 0.77
Event-related brain potentials in selective listening to frequent and rare stimuli. Psychophysiology (1990) 0.77
The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect (1993) 0.77
[A rapid dosimetric method for histamine challenge in asthma diagnosis]. Duodecim (1993) 0.77
[Physical basis of the generation of neuromagnetic fields]. Biofizika (1985) 0.76
The chloride shift may facilitate oxygen loading and unloading to/from the hemoglobin from the brown bear (Ursus arctos L.). Comp Biochem Physiol B (1990) 0.76
Modulation of slow brain potentials by working memory load in spatial and nonspatial auditory tasks. Neuropsychologia (2000) 0.76
[Subacute sclerosing panencephalitis in an adult]. Duodecim (1988) 0.75
Ceftriaxone versus latamoxef in febrile neutropenic patients: empirical monotherapy in patients with solid tumours. Eur J Cancer (1993) 0.75
Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one year follow-up. Psychol Med (1990) 0.75
[The development of adolescent psychiatry in Denmark]. Ugeskr Laeger (1971) 0.75
CSF beta-endorphin-like immunoreactivity in delirium. Biol Psychiatry (1989) 0.75
[Hyperkalemic periodic paralysis]. Duodecim (1988) 0.75
[The role of neurotransmitters in the pathogenesis and treatment of Alzheimer's disease]. Duodecim (1983) 0.75
[Status epilepticus--a problem in emergency medicine]. Duodecim (1991) 0.75
Differential effects of alcohol on the cortical processing of foreign and native language. Int J Psychophysiol (1998) 0.75
Dementia without cholinergic deficit. Gerontology (1987) 0.75
[Primary involvement of the central nervous system in acute leukemia]. Ugeskr Laeger (1983) 0.75
Cerebrospinal fluid somatostatin in delirium. Psychol Med (1989) 0.75
Visuospatial mnemonic load modulates event-related slow potentials. Neuroreport (1997) 0.75
Somatostatin and cognitive functions in Alzheimer's disease--the relationship of cerebrospinal fluid somatostatin increase with clinical response to tetrahydroaminoacridine. Neurosci Lett (1991) 0.75
Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study. Respiration (1992) 0.75
Comparison of the effects of carbamazepine and oxcarbazepine on peripheral nerve conduction. Epilepsy Res (1989) 0.75
[Mismatch negativity (MMN) to very short interval between regular tones]. Sheng Li Xue Bao (1994) 0.75
Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients. Neurosci Lett (1988) 0.75
Quantification of a number of biogenic amines and their metabolites in brain homogenates by gas chromatography--mass spectrometry. J Chromatogr (1984) 0.75